查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1288830

全球色素沉着病治疗市场研究报告 - 行业分析、规模、份额、增长、趋势和2023至2030年预测

Global Hyperpigmentation Disorder Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

据推测，到2030年，全球对色素沉着症治疗的需求将从2022年的5.8百万美元达到近11.73百万美元的市场规模，在2023-2030年研究期间的复合增长率为9.21%。

色素沉着症治疗是治疗色素沉着症的程序，这是一个与皮肤有关的问题。色素沉着是指与周围皮肤相比，变黑的皮肤上的斑块，通常导致斑点状或不均匀的外观。当黑色素细胞（一种皮肤变黑的色素）在皮肤深层产生黑色素时，就会发生色素沉着。黑色素的过度生产会导致皮肤的黑斑。黑色素合成的减少会导致皮肤色素沉着。药妆品、激光疗法和化学换肤都可以用来治疗色素沉着问题。

市场动态：

对尖端技术的研究和开发投资的增加可能会鼓励色素沉着症治疗的市场扩张。与色素沉着有关的社会耻辱的减少也可能有助于市场增长。与色素沉着有关的疾病发病率的增加，以及对皮肤再生和治疗方法认识的提高，预计将促进色素沉着症治疗市场。参与治疗色素沉着症的公司正在从药妆技术的改进和由此产生的药妆在皮肤护理中的使用的增加中获得经济利益，从而扩大色素沉着症治疗市场。主要参与者正在促进他们对纳米技术的投资，以开发创新和新的解决方案，这将有助于扩大色素沉着症治疗市场。

研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构，并在全球范围内评估竞争的吸引力。此外，这些工具还对全球色素沉着病治疗市场的每个细分市场进行了全面评估。色素沉着病治疗行业的增长和趋势为这项研究提供了一个全面的方法。

区域分析：

本节涵盖了区域前景，强调了北美、欧洲、亚太、拉丁美洲、中东和非洲的色素沉着症治疗市场的当前和未来需求。此外，该报告重点关注所有突出地区的个别应用部门的需求、估计和预测。

该研究报告还涵盖了市场中主要参与者的全面概况和对全球竞争格局的深入看法。色素沉着病治疗市场的主要参与者包括Aerolase公司、Candela公司、Cynosure、Galderma S.A.、iSCLINICAL、ISDIN、欧莱雅（SkinCeuticals、Skinbetterscience和La Roche-Posay）、LumenisBe有限公司、Mesoestetics、Obagi Cosmeceuticals LLC、PCA Skin、Scientis、Sente、SkinMedica（AbbVie）、SoltaMedical、ZO Skin Health Inc。这一部分包括对竞争格局的整体看法，其中包括各种战略发展，如关键的合并和收购，未来的能力，伙伴关系，财务概况，合作，新产品的开发，新产品的推出，以及其他发展。

如果你有任何定制要求，请写信给我们。我们的研究团队可以根据您的需要提供定制报告。

目录

第1章：前言

  • 报告描述
    • 目的
    • 目标受众
    • 独特的销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法

第二章：执行摘要

  • 市场的亮点
  • 全球市场简介

第三章：色素沉着病治疗 - 行业分析

  • 简介 - 市场动态
  • 市场驱动力
  • 市场限制因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 按治疗类型分類的市场吸引力分析
    • 市场吸引力分析（按疾病指征
    • 按终端用户分类的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商名单
    • 关键原材料的价格趋势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道的发展趋势

第五章：Covid-19爆发的影响分析

第六章：全球色素沉着病治疗市场分析：按治疗类型划分

  • 按治疗类型概述
  • 历史和预测数据
  • 按治疗类型分析
  • 药妆
  • 激光治疗
  • 化学换肤
  • 微晶磨皮
  • 光疗
  • 其他疗法

第7章 ：全球色素沉着症治疗市场分析：按疾病适应症分类

  • 按疾病适应症概述
  • 历史和预测数据
  • 按疾病适应症分析
  • 黄褐斑
  • 炎症后色素沉着症
  • 日光性色斑
  • 其他

第八章：全球色素沉着症治疗市场销售分析：按终端用户分类

  • 按终端用户概述
  • 历史和预测数据
  • 按终端用户分析
  • 医院
  • 美容诊所和皮肤科中心
  • 其他

第九章：全球色素沉着病治疗市场销售分析：按地域划分

  • 区域前景销售分析
  • 简介 销售分析
  • 北美洲销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美地区国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概况、历史和预测的销售分析
    • 欧洲分部销售分析
    • 欧洲国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概况、历史和预测的销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉美地区销售分析
    • 概况、历史和预测的销售分析
    • 拉美地区分部销售分析
    • 拉美地区国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉美其他地区销售分析
  • 中东和非洲销售分析
    • 概况、历史和预测销售分析
    • 中东和非洲地区分部销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第十章：色素沉着病治疗公司的竞争格局

  • 色素沉着病治疗的市场竞争
  • 伙伴关系/合作/协议
  • 合并和收购
  • 新产品发布
  • 其他方面的发展

第十一章 ：公司简介

  • 前10名公司份额分析
  • 市场集中度
  • Aerolase Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Candela Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Cynosure
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Galderma S.A.
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • iSCLINICAL
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • ISDIN
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • L'Oreal (SkinCeuticals Skinbetterscience & La Roche-Posay)
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • LumenisBe Ltd.
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Mesoestetics
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Obagi Cosmeceuticals LLC
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • PCA Skin
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Scientis
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Sente
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • SkinMedica (AbbVie)
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • SoltaMedical
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • ZO Skin Health Inc.
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展情况

注意 - 在公司简介中，财务细节和最近的发展情况要视情况而定，如果是私营公司，可能不包括在内。

Product Code: VMR11219996

The global demand for Hyperpigmentation Disorder Treatment Market is presumed to reach the market size of nearly USD 11.73 MN by 2030 from USD 5.8 MN in 2022 with a CAGR of 9.21% under the study period 2023 - 2030.

Hyperpigmentation disorder treatments are procedures to treat hyperpigmentation which is a skin-related concern. Pigmentation refers to patches on the darkened skin compared to the surrounding skin, typically resulting in a patchy or uneven look. Hyperpigmentation occurs when melanocytes, a skin-darkening pigment, generate melanin in the deep skin layers. An overproduction of melanin can cause dark patches of skin. A reduction in melanin synthesis results in skin hypopigmentation. Cosmeceuticals, laser therapy, and chemical peels can all be used to treat hyperpigmentation issues. 

Market Dynamics:

Increasing investments in research and development for cutting-edge technology may encourage market expansion for hyperpigmentation disorder treatments. The diminishing of social stigma associated with pigmentation may also aid market growth. The increased prevalence of hyperpigmentation-related disorders and increased awareness of skin rejuvenation and treatment alternatives are projected to boost the hyperpigmentation disorder treatment market. Companies involved in treating hyperpigmentation disorders are benefiting financially from cosmeceutical technological improvements and the resulting rise in cosmeceutical usage in skincare hence, expanding the hyperpigmentation disorder treatment market. Key players are boosting their investments in nanotechnology to develop innovative and new solutions that will help to broaden the hyperpigmentation disorder treatment market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hyperpigmentation disorder treatment. The growth and trends of hyperpigmentation disorder treatment industry provide a holistic approach to this study. 

Market Segmentation:

This section of the hyperpigmentation disorder treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Treatment Type

  • Cosmeceuticals
  • Laser Therapy
  • Chemical Peels
  • Microdermabrasion
  • Phototherapy
  • Others

By Disease Indication

  • Melasma
  • Post-Inflammatory Hyperpigmentation
  • Solar Lentigines
  • Others

By End-User

  • Hospitals
  • Esthetic Clinics & Dermatology Centers
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Hyperpigmentation Disorder Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hyperpigmentation disorder treatment market include Aerolase Corporation, Candela Corporation, Cynosure, Galderma S.A., iSCLINICAL, ISDIN, L'Oreal (SkinCeuticals, Skinbetterscience & La Roche-Posay), LumenisBe Ltd., Mesoestetics, Obagi Cosmeceuticals LLC, PCA Skin, Scientis, Sente, SkinMedica (AbbVie), SoltaMedical, ZO Skin Health Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HYPERPIGMENTATION DISORDER TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Treatment Type
    • 3.7.2 Market Attractiveness Analysis By Disease Indication
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET ANALYSIS BY TREATMENT TYPE

  • 6.1 Overview by Treatment Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Treatment Type
  • 6.4 Cosmeceuticals Historic and Forecast Sales by Regions
  • 6.5 Laser Therapy Historic and Forecast Sales by Regions
  • 6.6 Chemical Peels Historic and Forecast Sales by Regions
  • 6.7 Microdermabrasion Historic and Forecast Sales by Regions
  • 6.8 Phototherapy Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET ANALYSIS BY DISEASE INDICATION

  • 7.1 Overview by Disease Indication
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Disease Indication
  • 7.4 Melasma Historic and Forecast Sales by Regions
  • 7.5 Post-inflammatory Hyperpigmentation Historic and Forecast Sales by Regions
  • 7.6 Solar Lentigines Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET SALES ANALYSIS BY END-USER

  • 8.1 Overview by End-user
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-user
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Esthetic Clinics & Dermatology Centers Historic and Forecast Sales by Regions
  • 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HYPERPIGMENTATION DISORDER TREATMENT COMPANIES

  • 10.1. Hyperpigmentation Disorder Treatment Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF HYPERPIGMENTATION DISORDER TREATMENT INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Aerolase Corporation
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Candela Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Cynosure
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Galderma S.A.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. iSCLINICAL
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. ISDIN
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. L'Oreal (SkinCeuticals Skinbetterscience & La Roche-Posay)
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. LumenisBe Ltd.
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Mesoestetics
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Obagi Cosmeceuticals LLC
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. PCA Skin
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Scientis
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Sente
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. SkinMedica (AbbVie)
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. SoltaMedical
    • 11.17.1. Company Overview
    • 11.17.2. Company Revenue
    • 11.17.3. Products
    • 11.17.4. Recent Developments
  • 11.18. ZO Skin Health Inc.
    • 11.18.1. Company Overview
    • 11.18.2. Company Revenue
    • 11.18.3. Products
    • 11.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Treatment Type (USD MN)
  • Cosmeceuticals Market Sales by Geography (USD MN)
  • Laser Therapy Market Sales by Geography (USD MN)
  • Chemical Peels Market Sales by Geography (USD MN)
  • Microdermabrasion Market Sales by Geography (USD MN)
  • Phototherapy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Disease Indication (USD MN)
  • Melasma Market Sales by Geography (USD MN)
  • Post-inflammatory Hyperpigmentation Market Sales by Geography (USD MN)
  • Solar Lentigines Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Esthetic Clinics & Dermatology Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Hyperpigmentation Disorder Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hyperpigmentation Disorder Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Hyperpigmentation Disorder Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by Disease Indication
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Treatment Type (USD MN)
  • Cosmeceuticals Market Sales by Geography (USD MN)
  • Laser Therapy Market Sales by Geography (USD MN)
  • Chemical Peels Market Sales by Geography (USD MN)
  • Microdermabrasion Market Sales by Geography (USD MN)
  • Phototherapy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Disease Indication (USD MN)
  • Melasma Market Sales by Geography (USD MN)
  • Post-inflammatory Hyperpigmentation Market Sales by Geography (USD MN)
  • Solar Lentigines Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Esthetic Clinics & Dermatology Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.